US2005142619A1PendingUtilityA1

Antibodies to mammalian langerhans cell antigen and their uses

Assignee: SCHERING CORPPriority: Sep 25, 1998Filed: Jan 21, 2005Published: Jun 30, 2005

Est. expirySep 25, 2018(expired)· nominal 20-yr term from priority

Inventors:Valerie Duvert-Frances Jean-Jacques Pin Jenny Valladeau Valerie Clair Sem Saeland Serge Lebecque

C07K 16/2851C07K 14/705

PatentIndex Score

Cited by

References

Claims

Abstract

Purified mammalian DC cell surface protein, designated Langerin, nucleic acids encoding Langerin, and antibodies which specifically bind Langerin.

Claims

exact text as granted — not AI-modified

1 . An isolated antibody which selectively binds a mammalian polypeptide, said polypeptide characterized by: 
 a) binds with selectively to DCGM4 monoclonal antibody;    b) natural form of said polypeptide has a molecular weight by SDS PAGE of ˜40 kD; and    c) expressed on the cell surface of Langerhans cells.    
     
     
         2 . The antibody of  claim 1  which is a monoclonal antibody.  
     
     
         3 . A hybridoma that produces a monoclonal antibody of  claim 2 .  
     
     
         4 . The hybridoma of  claim 3 , which has ATCC Accession No. HB-12576.  
     
     
         5 - 15 . (canceled)

Join the waitlist — get patent alerts

Track US2005142619A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.